Although Roche/454 hasn't released Titanium amplicon sequencing yet, are there any 454 users here who have developed protocols/workarounds to sequence amplicons with Titanium chemistry?
-
-
In amplicon sequencing using 454 GS FLX, does sequencing ONLY start from the end with Linker B? Thank you. -
robhall -- You can sequence PCR products (amplicons) with the Titanium General Library method but employing their Low Molecular Weight (LMW) DNA variation. Basically you take your PCR product (70 - 800 bp), skip the fragmentation and size selection steps, polish the ends and then proceed with the standard library prep as normal. (There may be some minor variations or notes for LMW DNA so read the manual carefully before starting.) With this procedure vs. the standard amplicon procedure (using fusion primers) your PCR product is randomly oriented relative to the A and B adapters so you will get sequence reads from both ends of your PCR product.
para_seq -- The GS FLX Amplicon sequencing allows you to select either the A or B adapter to sequence from. There are two different emulsion PCR kits available which alternately orient the amplicon for sequencing; they are called emPCR Kit II (Primer A) and emPCR Kit III (Primer B). (emPCR Kit I is for shotgun libraries).Comment
-
kmcarr--
Thanks a lot.Comment
-
thanks kmcarr--we can give that a try. We are planning to multiplex and hoped to sequence from both directions at once, but I believe Roche/454 does have a tech bulletin for designing multiplex adapters with Titanium. We just wouldn't be able to control how equally we are sequencing in each orientation per amplicon.Comment
-
please also have a look at this thread:
flxlexComment
-
Hi kmcarr--Have you tried this? I'm curious if it has worked. My only worry is that the ligations won't work as well as they need to from PCR product ends, but I guess the end-polishing should take care of that?
-robhallComment
-
robhall -- No we have not done any LMW preps. But as you say, the end polishing should work as well on PCR products as fragmented DNA.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...Yesterday, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment